No.	Name of Lifestyle	Third Class	Second Class	First Class	Type	No. of Studies
1	Acetaminophen	Analgesic and anti-inflammatory drugs	Drug	Clinical characteristics	No statistical significance factor	1
2	Age at first of Anticoagulants	Anticoagulants	Drug	Clinical characteristics	No statistical significance factor	1
3	Antidiabetic drug	Antidiabetic	Drug	Clinical characteristics	Protective factor Risk factor No statistical significance factor	1
4	antihypertensive	Antihypertensive	Drug	Clinical characteristics	No statistical significance factor	1
5	Aspirin	Analgesic and anti-inflammatory drugs	Drug	Clinical characteristics	No statistical significance factor	1
6	Benign prostatic hypertrophy medication	Benign prostatic hypertrophy(BPH) medication	Drug	Clinical characteristics	Protective factor Risk factor No statistical significance factor	1
7	Blood pressure medication	Antihypertensive	Drug	Clinical characteristics	No statistical significance factor	1
8	Cholesterol-lowering drugs	Cholesterol-lowering drugs	Drug	Clinical characteristics	Protective factor No statistical significance factor	1
9	Cimetidine	Antiulcer drug	Drug	Clinical characteristics	No statistical significance factor	1
10	Cumulative use of Cimetidine	Antiulcer drug	Drug	Clinical characteristics	Risk factor No statistical significance factor	1
11	Cumulative use of Other H2 blockers	Antiulcer drug	Drug	Clinical characteristics	No statistical significance factor	1
12	Current of Anticoagulants	Anticoagulants	Drug	Clinical characteristics	No statistical significance factor	1
13	current vs.non- of Statin	Statin	Drug	Clinical characteristics	No statistical significance factor	1
14	Duration of us of Anticoagulants	Anticoagulants	Drug	Clinical characteristics	No statistical significance factor	1
15	Fibrates	Cholesterol-lowering drugs	Drug	Clinical characteristics	No statistical significance factor	1
16	Finasteride	Benign prostatic hypertrophy(BPH) medication	Drug	Clinical characteristics	Protective factor	1
17	Ibuprofen	Analgesic and anti-inflammatory drugs	Drug	Clinical characteristics	Risk factor No statistical significance factor	1
18	Indication of Anticoagulants	Anticoagulants	Drug	Clinical characteristics	No statistical significance factor	1
19	Insulin	Antidiabetic	Drug	Clinical characteristics	No statistical significance factor	1
20	Ketoprofen	Analgesic and anti-inflammatory drugs	Drug	Clinical characteristics	No statistical significance factor	1
21	Metformin	Antidiabetic	Drug	Clinical characteristics	Protective factor No statistical significance factor	2
22	Nonaspirin NSAID	Analgesic and anti-inflammatory drugs	Drug	Clinical characteristics	No statistical significance factor	1
23	Other cholesterol-lowering drugs	Cholesterol-lowering drugs	Drug	Clinical characteristics	No statistical significance factor	1
24	Other H2 blockers	Antiulcer drug	Drug	Clinical characteristics	No statistical significance factor	1
25	Statin	Statin	Drug	Clinical characteristics	Protective factor No statistical significance factor	4
26	Statin dose	Statin	Drug	Clinical characteristics	No statistical significance factor	1
27	Statin type	Statin	Drug	Clinical characteristics	Protective factor No statistical significance factor	1
28	Sulphonylurea	Antidiabetic	Drug	Clinical characteristics	No statistical significance factor	1
29	Thiazolidinedione	Antidiabetic	Drug	Clinical characteristics	No statistical significance factor	1
30	Thyroid medication	Thyroid medication	Drug	Clinical characteristics	No statistical significance factor	1
31	Time since first of Anticoagulants	Anticoagulants	Drug	Clinical characteristics	No statistical significance factor	1
32	Warfarin	Anticoagulants	Drug	Clinical characteristics	No statistical significance factor	1
33	yr of Cimetidine	Antiulcer drug	Drug	Clinical characteristics	No statistical significance factor	1
34	yr of H2 blockers	Antiulcer drug	Drug	Clinical characteristics	No statistical significance factor	1